These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 27902972

  • 1. Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.
    Schrijver WA, van Diest PJ, Dutch Distant Breast Cancer Metastases Consortium, Moelans CB.
    Oncotarget; 2017 Jan 10; 8(2):3111-3123. PubMed ID: 27902972
    [Abstract] [Full Text] [Related]

  • 2. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J, Song C, Tang H, Zhang C, Tang J, Li X, Chen B, Xie X.
    Breast Cancer Res; 2017 Jun 19; 19(1):72. PubMed ID: 28629464
    [Abstract] [Full Text] [Related]

  • 3. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.
    Ann Surg Oncol; 2014 Mar 19; 21(3):1046-54. PubMed ID: 24242678
    [Abstract] [Full Text] [Related]

  • 4. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
    Li W, Chang J, Tong D, Peng J, Huang D, Guo W, Zhang W, Li J.
    Oncotarget; 2017 May 30; 8(22):35783-35791. PubMed ID: 28415758
    [Abstract] [Full Text] [Related]

  • 5. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.
    J Natl Cancer Inst; 2015 Mar 30; 107(3):. PubMed ID: 25663689
    [Abstract] [Full Text] [Related]

  • 6. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 30; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 7. Global microRNA profiling of metastatic conjunctival melanoma.
    Mikkelsen LH, Andersen MK, Andreasen S, Larsen AC, Tan Q, Toft PB, Wadt K, Heegaard S.
    Melanoma Res; 2019 Oct 30; 29(5):465-473. PubMed ID: 30932942
    [Abstract] [Full Text] [Related]

  • 8. Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
    Pentheroudakis G, Spector Y, Krikelis D, Kotoula V, Meiri E, Malamou-Mitsi V, Fountzilas G, Sanden M, Pavlidis N, Benjamin H, Aharonov R.
    Clin Exp Metastasis; 2013 Apr 30; 30(4):431-9. PubMed ID: 23124598
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study.
    Marino AL, Evangelista AF, Vieira RA, Macedo T, Kerr LM, Abrahão-Machado LF, Longatto-Filho A, Silveira HC, Marques MM.
    BMC Cancer; 2014 Oct 02; 14():739. PubMed ID: 25277099
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H, Lobo J, Salta S, Amorim M, Lopes P, Cantante M, Reis B, Antunes L, Castro F, Palma de Sousa S, Gonçalves CS, Costa BM, Henrique R, Jerónimo C.
    J Transl Med; 2019 Dec 30; 17(1):435. PubMed ID: 31888645
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
    Zhang G, Zhang W, Li B, Stringer-Reasor E, Chu C, Sun L, Bae S, Chen D, Wei S, Jiao K, Yang WH, Cui R, Liu R, Wang L.
    Breast Cancer Res; 2017 Jun 21; 19(1):73. PubMed ID: 28637482
    [Abstract] [Full Text] [Related]

  • 12. Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
    Huo D, Clayton WM, Yoshimatsu TF, Chen J, Olopade OI.
    Oncotarget; 2016 Aug 23; 7(34):55231-55248. PubMed ID: 27409424
    [Abstract] [Full Text] [Related]

  • 13. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
    Wang J, Li Z, Ge Q, Wu W, Zhu Q, Luo J, Chen L.
    J Thorac Cardiovasc Surg; 2015 May 23; 149(5):1404-14.e4. PubMed ID: 25813410
    [Abstract] [Full Text] [Related]

  • 14. Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients.
    Ibrahim AM, Said MM, Hilal AM, Medhat AM, Abd Elsalam IM.
    Tumour Biol; 2020 Oct 23; 42(10):1010428320963811. PubMed ID: 33028151
    [Abstract] [Full Text] [Related]

  • 15. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.
    Hamam R, Ali AM, Alsaleh KA, Kassem M, Alfayez M, Aldahmash A, Alajez NM.
    Sci Rep; 2016 May 16; 6():25997. PubMed ID: 27180809
    [Abstract] [Full Text] [Related]

  • 16. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F, Mowla SJ, Honardoost MA, Arjenaki MG, Moazeni-Bistgani M, Kheiri S, Teimori H.
    Tumour Biol; 2017 Aug 16; 39(8):1010428317698362. PubMed ID: 28857013
    [Abstract] [Full Text] [Related]

  • 17. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 18. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C, Tan W, Chen K, You N, Zhu S, Liang G, Xie X, Li Q, Zeng Y, Ouyang N, Li Z, Zeng M, Zhuang S, Lau WY, Liu Q, Yin D, Wang X, Su F, Song E.
    EBioMedicine; 2016 Sep 01; 11():199-209. PubMed ID: 27566954
    [Abstract] [Full Text] [Related]

  • 19. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D, Zhong J, Koetz L, Gaziel-Sovran A, Lackaye DJ, Shang S, Pavlick A, Shapiro R, Berman R, Darvishian F, Shao Y, Osman I, Hernando E.
    Clin Cancer Res; 2015 Nov 01; 21(21):4903-12. PubMed ID: 26089374
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.